Target Identification and Validation in Antiparasitic Drug Discovery

Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates

Volumn , Issue , 2009, Pages 59-73

  Wolf, Christian ^a   Gunkel, Nikolas ^a  

^a Intervet Innovation GmbH   (Germany)

Author keywords

Antiparasitic drugs; Drug discovery; Target identification; Target validation

Indexed keywords

EID: 84884093348     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527626816.ch5     Document Type: Chapter

References (50)

1. Brown, D. (2007) Unfinished business: target-based drug discovery. Drug Discovery Today, 12, 23-24.
2. Butcher, E.C. (2005) Can cell systems biology rescue drug discovery? Nature Reviews Drug Discovery, 4, 461-467.
3. Horrobin, D.F. (2003) Modern biomedical research: an internally self-consistent universe with little contact with medical reality? Nature Reviews Drug Discovery, 2, 151-154.
4. Milne, G.M. (2003) Pharmaceutical productivity-the imperative for new paradigms. Annual Reports in Medicinal Chemistry, 2003, 383-396.
5. Kola, I. and Landis, J. (2004) Can the pharmaceutical industry reduce attrition rates? Nature Reviews. Drug Discovery, 8, 711-5.
6. Campbell, W.C. and Fisher, M.H. (1993) Ivermectin, an antiparasitic agent. Medicinal Research Reviews, 13, 61-79.
7. Kaminsky, R., Ducray, P., Jung, M., Clover, R., Rufener, L., Bouvier, J., Schorderet-Weber, S. et al. (2008) A new class of anthelmintics effective against drug-resistant nematodes. Nature, 452, 176-180.
8. Rust, M.K. (2005) Advances in the control of Ctenocephalides felis (cat flea) on cats and dogs. Trends in Parasitiology, 21, 232-236.
9. Davey, R.B., Miller, R.J. and George, J.E. (2008) Efficacy of amitraz applied as a dip against an amitraz-resistant strain of Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) infested on cattle. Veterinary Parasitology, 152, 127-135.
10. Colditz, I.G. (2008) Six costs of immunity to gastrointestinal nematode infections. Parasite Immunology, 30, 63-70.
11. Du, W., Awolola, T.S., Howell, P., Koekemoer, L.L., Brooke, B.D., Benedict, M.Q., Coetzee, M. and Zheng, L. (2005) Independent mutations in the Rdl locus confer dieldrin resistance to Anopheles gambiae and An. Arabiensis. Insect Molecular Biology, 14, 179-183.
12. Daborn, P.J., Yen, J.L., Bogwitz, M.R., Le Goff, G., Feil, E., Jeffers, S., Tijet, N. et al. (2002) A single P450 Allele associated with insecticide resistance in Drosophila. Science, 297, 2253-2256.
13. Driscoll, M., Dean, E., Reilly, E., Bergholz, E. and Chalfie, M. (1989) Genetic and molecular analysis of a Caenorhabditis elegans beta-tubulin that conveys benzimidazole sensitivity. Journal of Cell Biology, 109, 2993-3003.
14. Sams-Dodd, F. (2006) Strategies to optimize the validity of disease models in the drug discovery process. Drug Discovery Today, 11, 355-363.
15. Le Goff, G., Hamon, A., Berge, J.B. and Amichot, M. (2005) Resistance to fipronil in Drosophila simulans: influence point mutations in the RDL GABA receptor subunit. Journal of Neurochemistry, 92, 1295-1305.
16. McKenzie, J.A. and Batterham, P. (1998) Predicting insecticide resistance: mutagenesis, selection and response. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 353, 1729-1734.
17. Ffrench-Constant, R.H., Rocheleau, T.A., Steichen, J.C. and Chalmers, A.E. (1993) A point mutation in a Drosophila GABA receptor confers insecticide resistance. Nature, 363, 449-451.
18. Hosie, A.M., Baylis, H.A., Buckingham, S.D. and Sattelle, D.B. (1995) Actions of the insecticide fipronil, on dieldrin-sensitive and-resistant GABA receptors of Drosophila melanogaster. British Journal of Pharmacology, 115, 909-912.
19. Bass, C., Schroeder, I., Turberg, A., Field, L.M. and Williamson, M.S. (2004) Identification of the Rdl mutation in laboratory and field strains of the cat flea, Ctenocephalides felis (Siphonaptera: Pulicidae). Pest Management Science, 60, 1157-1162.
20. Zhao, X., Yeh, J.Z., Salgado, V.S. and Narahashi, T. (2004) Fipronil is a potent open channel blocker of glutamate-activated chloride channels in cockroach neurons. Journal of Pharmacology and Experimental Therapeutics, 310, 192-201.
21. Jones, A.K., Buckingham, S.D. and Sattelle, D.B. (2005) Chemistry-to-gene screens in Caenorhabditis elegans. Nature Reviews. Drug Discovery, 4, 321-330.
22. Brown, L.A., Jones, A.K., Buckingham, S.D., Mee, C.J. and Sattelle, D.B. (2006) Contributions from Caenorhabditis elegans functional genetics to antiparasitic drug target identification and validation: nicotinic acetylcholine receptors, a case study. International Journal for Parasitology, 36, 617-624.
23. Krasky, A., Rohwer, A., Schroeder, J. and Selzer, P.M. (2007) A combined bioinformatics and chemoinformatics approach for the development of new antiparasitic drugs. Genomics, 89, 36-43.
24. Venken, K.J.T. and Bellen, H.J. (2007) Transgenesis upgrades for Drosophila melanogaster. Development (Cambridge, England), 134, 3571-3584.
25. St Johnston, D. (2002) The art and design of genetic screens: Drosophila melanogaster. Nature Reviews. Genetics, 3, 176-188.
26. Kamath, R.S., Fraser, A.G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A. et al. (2003) Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature, 421, 231-237.
27. Lee, Y.S. and Carthew, R.W. (2003) Making a better RNAi vector for Drosophila: use of intron spacers. Methods (San Diego, Calif), 30, 322-329.
28. Nijhofa, A.M., Taoufika, A., de la Fuenteb, J., Kocanb, K.M., de Vriesa, E. and Jongejan, F. (2007) Gene silencing of the tick protective antigens, Bm86, Bm91 and subolesin, in the one-host tick Boophilus microplus by RNA interference. International Journal for Parasitology, 37, 653-662.
29. Knox, D.P., Geldhof, P., Visser, A. and Britton, C. (2007) RNA interference in parasitic nematodes of animals: a reality check? Trends in Parasitology, 23, 105-107.
30. Zawadzki, J.L., Presidente, P.J., Meeusen, E.N. and De Veer, M.J. (2006) RNAi in Haemonchus contortus: a potential method for target validation. Trends in Parasitology, 22, 495-499.
31. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E. and Mello, C.C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 19, 806-11.
32. Fire, A. (1999) RNA-triggered gene silencing. Trends in Genetics, 15, 358-363.
33. Roignant, J.Y., Carre, C., Mugat, B., Szymczak, D., Lepesant, J.A. and Antoniewski, C. (2003) Absence of transitive and systemic pathways allows cell-specific and isoform-specific RNAi in Drosophila. RNA (New York, NY), 9, 299-308.
34. Brand, A.H. and Perrimon, N. (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development (Cambridge, England), 118, 401-415.
35. Dietzl, G., Chen, D., Schnorrer, F., Su, K.C., Barinova, Y., Fellner, M., Gasser, B. et al. (2007) A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature, 448, 151-156.
36. Roman, G., Endo, K., Zong, L. and Davis, R.L. (2001) P[Switch], a system for spatial and temporal control ofgene expression in Drosophila melanogaster. Proceedings of the National Academy of Sciences of the United States of America, 23, 2602-2607.
37. McGuire, S.E., Le, P.T., Osborn, A.J., Matsumoto, K. and Davis, R.L. (2003) Spatiotemporal rescue of memory dysfunction in Drosophila. Science, 5, 1765-1768.
38. Zeidler, M.P., Tan, C., Bellaiche, Y., Cherry, S., Hader, S., Gayko, U. and Perrimon, N. (2004) Temperaturesensitive control of protein activity by conditionally splicing inteins. Nature Biotechnology, 22, 871-876.
39. Siegal, M.L. and Hartl, D.L. (1996) Transgene coplacement and high efficiency site-specific recombination with the Cre/loxP system in Drosophila. Genetics, 144, 715-726.
40. Theodosiou, N.A. and Xu, T. (1998) Use of FLP/FRT system to study Drosophila development. Methods (San Diego, Calif), 14, 355-365.
41. Stebbins, M.J., Urlinger, S., Byrne, G., Bello, B., Hillen, W. and Yin, J.C. (2001) Tetracycline-inducible systems for Drosophila. Proceedings of the National Academy of Sciences of the United States of America, 11, 10775-10780.
42. Tasaki, T. and Kwon, Y.T. (2007) The mammalian N-end rule pathway: new insights into its components and physiological roles. Trends in Biochemical Sciences, 32, 520-528.
43. Rørth, P., Szabo, K., Bailey, A., Laverty, T., Rehm, J., Rubin, G.M., Weigmann, K. et al. (1998) Systematic gain-of-function genetics in Drosophila. Development (Cambridge, England), 125, 1049-1057.
44. Hayashi, S., Ito, K., Sado, Y., Taniguchi, M., Akimoto, A., Takeuchi, H., Aigaki, T. et al. (2002) GETDB, a database compiling expression patterns and molecular locations of a collection of Gal4 enhancer traps. Genesis (New York, NY: 2000), 34, 58-61.
45. Chalmers, D.T. and Behan, D.P. (2002) The use of constitutively active GPCRs in drug discovery and functional genomics. Nature Reviews. Drug Discovery, 1, 599-608.
46. Nellen, D., Burke, R., Struhl, G. and Basler, K. (1996) Direct and long-range action of a DPP morphogen gradient. Cell, 85, 357-368.
47. Nicholson, G.M. (2007) Insect-selective spider toxins targeting voltage-gated sodium channels. Toxicon, 49, 490-512.
48. Enan, E.E. (2005) Molecular response of Drosophila melanogaster tyramine receptor cascade to plant essential oils. Insect Biochemistry and Molecular Biology, 35, 309-321.
49. Matthews, D.J. and Kopczynski, J. (2001) Using model-system genetics for drug-based target discovery. Drug Discovery Today, 6, 141-149.
50. Terstappen, G.C., SchKipen, C., Raggiaschi, R. and Gaviraghi, G. (2007) Target deconvolution strategies in drug discovery. Nature Reviews. Drug Discovery, 6, 891-903.